DIFFERENCE IN ORAL EFFECTIVENESS OF 2 TYROSINE HYDROXYLASE INHIBITORS

[1] AZARKH R M, 1960, Biokhimiia, V25, P954

[2] A FLUORIMETRIC METHOD FOR THE DETERMINATION OF DOPAMINE (3-HYDROXYTYRAMINE) [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1958, 44 (3-4): : 293 - 298

[3] INHIBITION OF ENDOGENOUS CATECHOLAMINE BIOSYNTHESIS BY 3-IODO-L-TYROSINE [J]. BIOCHEMICAL PHARMACOLOGY, 1965, 14 (12) : 1914 - +

[4] GOLDSTEIN MENEK, 1965, LIFE SCI, V4, P261, DOI 10.1016/0024-3205(65)90126-8

[5] JACOBY GA, 1964, J BIOL CHEM, V239, P419

[6] MATSUMOTO T, 1958, Kekkaku, V33, P338

[7] MATSUMOTO T, 1958, CA 20656I, V52

[8] MOORE K E, 1965, Pharmacologist, V7, P170

[9] MOORE KE, 1966, FED PROC, V25, P688

[10] MOORE KENNETH E., 1966, LIFE SCI, V5, P55, DOI 10.1016/0024-3205(66)90187-1

[1] AZARKH R M, 1960, Biokhimiia, V25, P954

[2] A FLUORIMETRIC METHOD FOR THE DETERMINATION OF DOPAMINE (3-HYDROXYTYRAMINE) [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1958, 44 (3-4): : 293 - 298

[3] INHIBITION OF ENDOGENOUS CATECHOLAMINE BIOSYNTHESIS BY 3-IODO-L-TYROSINE [J]. BIOCHEMICAL PHARMACOLOGY, 1965, 14 (12) : 1914 - +

[4] GOLDSTEIN MENEK, 1965, LIFE SCI, V4, P261, DOI 10.1016/0024-3205(65)90126-8

[5] JACOBY GA, 1964, J BIOL CHEM, V239, P419

[6] MATSUMOTO T, 1958, Kekkaku, V33, P338

[7] MATSUMOTO T, 1958, CA 20656I, V52

[8] MOORE K E, 1965, Pharmacologist, V7, P170

[9] MOORE KE, 1966, FED PROC, V25, P688

[10] MOORE KENNETH E., 1966, LIFE SCI, V5, P55, DOI 10.1016/0024-3205(66)90187-1